Dr Martens PLC banner

Dr Martens PLC
OTC:DOCMF

Watchlist Manager
Dr Martens PLC Logo
Dr Martens PLC
OTC:DOCMF
Watchlist
Price: 1.03 USD 4.78% Market Closed
Market Cap: $990.6m

Wall St Price Targets

DOCMF Price Targets Summary
Dr Martens PLC

Wall Street analysts forecast DOCMF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DOCMF is 1.39 USD with a low forecast of 0.96 USD and a high forecast of 2.01 USD.

Lowest Forecast
Price Target
0.96 USD
7% Downside
Average Forecast
Price Target
1.39 USD
35% Upside
Highest Forecast
Price Target
2.01 USD
95% Upside
Dr Martens PLC Competitors:
Price Targets
TYRA
Tyra Biosciences Inc
63% Upside
4088
Air Water Inc
15% Upside
WSC
Willscot Mobile Mini Holdings Corp
5% Upside

Revenue
Forecast

10% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
10% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 6 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 8 years is 4%.

Gross Profit
Forecast

12% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
12% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

Over the last 6 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 5 years is 4%.

Operating Income
Forecast

-1% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
6%
Average Beat
-1% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
6%
Average Beat

Over the last 6 years, the compound annual growth rate for Operating Income has been -1%. The projected CAGR for the next 8 years is 10%.

Pre-Tax Income
Forecast

-18% / Year
Past Growth
116% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss
-18% / Year
Past Growth
116% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Over the last 6 years, the compound annual growth rate for Pre-Tax Income has been -18%. The projected CAGR for the next 3 years is 116%.

Net Income
Forecast

-20% / Year
Past Growth
100% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
-20% / Year
Past Growth
100% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Over the last 6 years, the compound annual growth rate for Net Income has been -20%. The projected CAGR for the next 4 years is 100%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is DOCMF's stock price target?
Price Target
1.39 USD

According to Wall Street analysts, the average 1-year price target for DOCMF is 1.39 USD with a low forecast of 0.96 USD and a high forecast of 2.01 USD.

What is the Revenue forecast for Dr Martens PLC?
Projected CAGR
4%

Over the last 6 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 8 years is 4%.

What is the Gross Profit forecast for Dr Martens PLC?
Projected CAGR
4%

Over the last 6 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 5 years is 4%.

What is the Operating Income forecast for Dr Martens PLC?
Projected CAGR
10%

Over the last 6 years, the compound annual growth rate for Operating Income has been -1%. The projected CAGR for the next 8 years is 10%.

What is the Pre-Tax Income forecast for Dr Martens PLC?
Projected CAGR
116%

Over the last 6 years, the compound annual growth rate for Pre-Tax Income has been -18%. The projected CAGR for the next 3 years is 116%.

What is the Net Income forecast for Dr Martens PLC?
Projected CAGR
100%

Over the last 6 years, the compound annual growth rate for Net Income has been -20%. The projected CAGR for the next 4 years is 100%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett